With global healthcare costs increasing year on year, wearable healthcare devices can provide significant benefits in terms of improving the healthcare whilst reducing costs.
Globally healthcare costs are growing to 10% of global GDP and this equates to around USD 9 trillion a year.
As technology develops, there is a mindset shift from just basic monitoring to reactive monitoring for prevention and early detection in addition to the on-going monitoring. This can not only reduce costs but result in better outcomes.
Consumer wearable fitness devices do not give much useful information and this is why the market has stagnated recently. However there is much more that can be done. Heart disease and diabetes are two areas where there are many devices available.
To meet the growing needs for more sophisticated wearable healthcare, Maxim has introduced new devices. The MAX86140 and MAX86141 optical pulse oximeter/heart rate sensors and the MAX30001 electrocardiogram (ECG) and bioimpedance (BioZ) analogue front end (AFE) from Maxim Integrated Products, Inc. (NASDAQ: MXIM). These devices would not have been considered for incorporation into wearable devices, indicating how technology is moving on.
Through compact, low power solutions, these devices enable accurate monitoring of vital signs to monitor wellness/fitness and prevent health problems before they even begin. Today's continuous monitoring technology is shifting the consumer mindset away from a reactive monitoring approach to a proactive one.
The MAX86140 and MAX86141 can be used to measure PPG signals on the wrist, finger, and ear to detect heart rate, heart rate variability, and pulse oximetry. The MAX30001 measures ECG and BioZ on the chest and wrist to detect heart rate, respiration, and arrhythmias. Compared to competitive solutions, the MAX86140 and MAX86141 require less than half the power and is approximately one third smaller, while the MAX30001 requires approximately half the power in almost half the size. By collecting beat to beat data about the heart, these solutions collect accurate data so users can recognize important symptoms when they first begin. In addition, the MAX30001 meets IEC60601-2-47, clinical ECG standards.
Rather than waiting for yearly doctor visits to get results for blood pressure and other vital signs, consumers want real-time information about the status of their health. This shift is causing an increased demand for accurate, small, and low-power wearable devices-an important enabler for this new way of thinking. As continuous monitoring and preventive healthcare become more common, both technology providers and health practitioners must embrace and accommodate these new demands to be successful.
Maxim's portfolio of sensors for wearable health and fitness applications allows consumers to accurately monitor a variety of key vital signs while being mindful of low power (for longer battery life) and small size (for convenience and comfort).
(C) 2017 Electronic News Publishing, source ENP Newswire